A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination-Reference-Cited by-同舟云学术

A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination

Published:2020-06 Issue:27 Volume:38 Page:4316-4324
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Batmunkh Tsetsegsaihan,Dalmau Marguerite T.,Munkhsaikhan Margad-Erdene,Khorolsuren Tungalagtuya,Namjil Narantuya,Surenjav Unursaikhan,Toh Zheng Quan,Licciardi Paul V.,Russell Fiona M.,Garland Suzanne M.,Mulholland Kim,von Mollendorf Claire

Funder

Bill & Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference28 articles.

1. A review of clinical trials of human papillomavirus prophylactic vaccines;Schiller;Vaccine,2012

2. Garland SM, Pitisuttithum P, Ngan HYS, et al. Efficacy, immunogenicity and safety of a 9-valent human papillomavirus vaccine: subgroup analysis of participants from Asian countries. J Infect Dis. 2018;218(1): 95–108. Published online 2018 May 15. doi: 10.1093/infdis/jiy133.

3. World Health Organization. Evidence based recommendations on Human Papilloma Virus (HPV) Vaccine Schedules. Background paper for SAGE discussions [Internet]. 2014 [cited 2019 April 8]. Available from: https://www.who.int/immunization/sage/meetings/2014/april/1_HPV_Evidence_based_recommendationsWHO_with_Appendices2_3.pdf.

4. Kreimer AR, Herrero R, Sampson JN, et al. Evidence for single-dose protection by the bivalent HPV vaccine-review of the Costa Rica HPV vaccine trial and future research studies. Vaccine 2018;36(32 Pt A): 4774-4782. https://10.1016/j.vaccine.2017.12.078.

5. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials;Kreimer;Lancet Oncol,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the seroprevalence of human papillomavirus in Guangdong, China: Implications for vaccination strategies;Journal of Medical Virology;2024-09

2. The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination;Vaccines;2024-08-23

3. Fifteen years of vaccination against the human papilloma virus in Spain. An update;Vacunas (English Edition);2023-10

4. Quince años de vacunación frente al virus del papiloma humano en España. Actualización;Vacunas;2023-10

5. Unraveling Immunological Dynamics: HPV Infection in Women—Insights from Pregnancy;Viruses;2023-09-27